Seems like these guys are really selective about the kind of financing they want to take on, that's the reason for the new hire in the latest press release. The greatest potential here is for, of course, the Metformin eye drops (versus injection...yuck!), which another poster cleverly put it in another post as "a no brainer". I truly believe that they are going to get a partner, since the only thing in question for the study is the form of delivery and dosage.
It never fails though, and that's what I like about the potential here, is that you will so focused on Metformin, when they blind side you with good news about their other candidate drugs or take on a new one. You are not banking on the drugs themselves, here, but the expertise of those involved to take on proven drugs and moving them, when others couldn't for various reasons laid out in the interview, to the next level and then out to market. A truly great business plan. We're going to be rich here. ALL IMO
News 
Market Data 
Discover 
